Stay updated on CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial
Sign up to get notified when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.

Latest updates to the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4 for the study record history.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedUpdates the ClinicalTrials.gov page revision/version label from v3.5.2 to v3.5.3, indicating a minor site build or UI release rather than a change to the underlying clinical trial record.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the Record History page.SummaryDifference0.1%

- Check85 days agoChange DetectedThe record history now shows a new site revision (v3.4.3) added, replacing the previous revision (v3.4.2).SummaryDifference0.1%

- Check92 days agoChange DetectedNew Study Status and Recruitment Status entries were added, including a Terminated status on 2026-03-03, a 2026-02-27 update (version 16), and a <75% participation indicator. The previous 'Active, not recruiting' status entry was removed (as of 2025-11-21).SummaryDifference0.6%

Stay in the know with updates to CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.